Walter Reed National Military Medical Center
Trial Pipeline
Transtibial Osseointegration
NCT06636136
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
NCT06729151
Bladder Botox UTI Antibiotic Prophylaxis
NCT06387329
New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome
NCT06204874
Tender Loving Care for Recurrent Pregnancy Loss
NCT06182878
Microbiome Population Adaptation Study
NCT06310239
Cognitive and Vascular Functioning Following TBI
NCT06034509
Post-Concussion Musculoskeletal Injury Risks
NCT05122728
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
NCT05221021
Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
NCT05414708
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
NCT06275373
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
NCT06247267
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
NCT04020510
Combined Cryotherapy With Compression Versus Cryotherapy Alone After Orthopaedic Surgery
NCT05011084
Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy
NCT04032327
The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes
NCT01741467
The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes
NCT01648244
The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes
NCT01738802
Sutureless Cryopreserved Amniotic Membrane Graft (ProKera) and Wound Healing After Photorefractive Keratectomy
NCT00915759
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 30 |
What the Pipeline for Walter Reed National Military Medical Center Shows
According to the ClinicalTrials.gov registry, Walter Reed National Military Medical Center is linked to 73 US clinical trials across every stage of research activity. Of those, 67 studies are currently recruiting — about 92% of the sponsor's indexed portfolio — and 5 are already marked complete, representing roughly 7% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Walter Reed National Military Medical Center reports 30 late-stage studies (Phase 3 and Phase 4 combined) and 1 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Walter Reed National Military Medical Center is Bladder Pain Syndrome with 3 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.